Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""CLINICAL trials"" wg kryterium: Temat


Starter badań:

Tytuł:
Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence.
Autorzy:
Helanterä I; Department of Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Snyder J; Hennepin Healthcare Research Institute, Minneapolis, MN, United States.
Åsberg A; Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.; Department of Pharmacy, University of Oslo, Oslo, Norway.
Cruzado JM; Department of Nephrology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Clinical Sciences Department, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Bell S; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.; The Scottish Renal Registry, Scottish Health Audits, Public Health and Intelligence, Information Services, Glasgow, United Kingdom.
Legendre C; Hôpital Necker, Assistance Publique Hôpitaux de Paris (AP-HP) and Université Paris Descartes, Paris, France.
Tedesco-Silva H Jr; Nephrology Division, Hospital do Rim, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Barcelos GT; Novartis Pharma AG, Basel, Switzerland.
Geissbühler Y; Novartis Pharma AG, Basel, Switzerland.
Prieto L; Novartis Pharma AG, Basel, Switzerland.
Christian JB; IQVIA Real-World Solutions, Durham, NC, United States.
Scalfaro E; IQVIA Real-World Solutions, Basel, Switzerland.
Dreyer NA; IQVIA Real-World Solutions, Cambridge, MA, United States.
Pokaż więcej
Źródło:
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 May 03; Vol. 35, pp. 10329. Date of Electronic Publication: 2022 May 03 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Kidney Transplantation*/adverse effects
Pragmatic Clinical Trials as Topic*/standards
Risk Assessment*
Clinical Trials as Topic/standards ; Graft Survival ; Humans ; Research Design/standards
Czasopismo naukowe
Tytuł:
Practical and robust test for comparing binomial proportions in the randomized phase II setting.
Autorzy:
Attwood K; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Park S; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Department of Biostatistics, University at Buffalo, Buffalo, New York, USA.
Hutson AD; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Pokaż więcej
Źródło:
Pharmaceutical statistics [Pharm Stat] 2022 Mar; Vol. 21 (2), pp. 361-371. Date of Electronic Publication: 2021 Oct 09.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Clinical Trials, Phase II as Topic*
Randomized Controlled Trials as Topic*
Research Design*
Clinical Trials, Phase III as Topic ; Humans ; Neoplasms ; Sample Size
Czasopismo naukowe
Tytuł:
The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?
Autorzy:
Steele L; Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.; Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Lee HL; Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Maruthappu T; Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
O'Toole EA; Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.; Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Oct; Vol. 46 (7), pp. 1290-1292. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Publication Bias*
Registries*
Alopecia Areata/*drug therapy
Janus Kinase Inhibitors/*therapeutic use
Databases, Factual ; Early Termination of Clinical Trials ; Humans ; Meta-Analysis as Topic ; Treatment Failure
Czasopismo naukowe
Tytuł:
Early completion of phase I cancer clinical trials with Bayesian optimal interval design.
Autorzy:
Kojima M; Biometrics Department, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan.; Department of Statistical Science, School of Multidisciplinary Sciences, The Graduate University for Advanced Studies, Tokyo, Japan.
Pokaż więcej
Źródło:
Statistics in medicine [Stat Med] 2021 Jun 30; Vol. 40 (14), pp. 3215-3226. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji:
Journal Article
MeSH Terms:
Early Termination of Clinical Trials*
Models, Statistical*
Neoplasms*/therapy
Bayes Theorem ; Clinical Trials, Phase I as Topic ; Computer Simulation ; Dose-Response Relationship, Drug ; Humans
Czasopismo naukowe
Tytuł:
Melanoma trials that defined surgical management.
Autorzy:
Faries MB; The Angeles Clinic and Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Journal of surgical oncology [J Surg Oncol] 2022 Jan; Vol. 125 (1), pp. 34-37.
Typ publikacji:
Historical Article; Journal Article; Review
MeSH Terms:
Clinical Trials as Topic/*methods
Lymph Nodes/*surgery
Melanoma/*surgery
Clinical Trials as Topic/history ; Clinical Trials, Phase III as Topic/history ; Clinical Trials, Phase III as Topic/methods ; History, 19th Century ; History, 20th Century ; History, 21st Century ; Humans ; Lymph Node Excision ; Lymph Nodes/pathology ; Lymphatic Metastasis ; Melanoma/history ; Melanoma/pathology ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic/history ; Randomized Controlled Trials as Topic/methods ; Sentinel Lymph Node Biopsy/methods
Czasopismo naukowe
Tytuł:
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis.
Autorzy:
Parker JL; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Kuzulugil SS; St Michael's Hospital, Toronto, ON, Canada.
Pereverzev K; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Mac S; Institute of Health Policy, Management and Evaluation, University of Toronto, Mississauga, ON, Canada.
Lopes G; University of Miami, Miller School of Medicine, Coral Gables, FL, USA.
Shah Z; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Weerasinghe A; Prevention and Cancer Control, Cancer Care Ontario, Toronto, ON, Canada.
Rubinger D; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Falconi A; Department of Pharmacy, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
Bener A; Mechanical and Industrial Engineering, Ryerson University, Toronto, ON, Canada.
Caglayan B; Mechanical and Industrial Engineering, Ryerson University, Toronto, ON, Canada.
Tangri R; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Mitsakakis N; Institute of Health Policy, Management and Evaluation, and Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Mar; Vol. 10 (6), pp. 1955-1963. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*/classification
Biomarkers, Tumor*/genetics
Clinical Trials as Topic*/classification
Clinical Trials as Topic*/statistics & numerical data
Drug Approval*/methods
Drug Approval*/statistics & numerical data
Markov Chains*
Antineoplastic Agents/*therapeutic use
Neoplasms/*drug therapy
Breast Neoplasms/chemistry ; Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Carcinoma, Non-Small-Cell Lung/chemistry ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Colorectal Neoplasms/chemistry ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/genetics ; Databases, Factual/statistics & numerical data ; Female ; Genetic Markers ; Humans ; Lung Neoplasms/chemistry ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Male ; Medical Oncology ; Melanoma/chemistry ; Melanoma/drug therapy ; Melanoma/genetics ; Neoplasms/chemistry ; Neoplasms/genetics ; Risk ; Skin Neoplasms/chemistry ; Skin Neoplasms/drug therapy ; Skin Neoplasms/genetics ; Stochastic Processes ; Time Factors ; Treatment Failure
Czasopismo naukowe
Tytuł:
A systematic review of methods used to conduct decentralised clinical trials.
Autorzy:
Rogers A; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
De Paoli G; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Subbarayan S; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Copland R; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Harwood K; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Coyle J; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Mitchell L; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
MacDonald TM; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Mackenzie IS; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Pokaż więcej
Corporate Authors:
Trials@Home Consortium; https://trialsathome.com.
Źródło:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jun; Vol. 88 (6), pp. 2843-2862. Date of Electronic Publication: 2022 Jan 27.
Typ publikacji:
Journal Article; Systematic Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Clinical Trials as Topic*
Delivery of Health Care*
Humans ; Qualitative Research ; Research Design
Czasopismo naukowe
Tytuł:
Risk-based centralized data monitoring of clinical trials at the time of COVID-19 pandemic.
Autorzy:
Afroz MA; Department of Electrical and Electronic Engineering, Begum Rokeya University, Rangpur, Bangladesh.
Schwarber G; Department of Biostatistics, Medpace, Inc., 5375 Medpace Way, Cincinnati, OH 45227, USA.
Bhuiyan MAN; Department of Biostatistics, Medpace, Inc., 5375 Medpace Way, Cincinnati, OH 45227, USA.. Electronic address: .
Pokaż więcej
Źródło:
Contemporary clinical trials [Contemp Clin Trials] 2021 May; Vol. 104, pp. 106368. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Clinical Trials as Topic*/economics
Clinical Trials as Topic*/methods
Clinical Trials as Topic*/organization & administration
Data Accuracy*
Multicenter Studies as Topic*
Risk Management*/methods
Risk Management*/trends
Research Design/*trends
Change Management ; Clinical Trials Data Monitoring Committees/organization & administration ; Communicable Disease Control/methods ; Cost-Benefit Analysis ; Humans ; Risk Adjustment/methods ; Risk Adjustment/trends ; Risk Assessment/methods ; SARS-CoV-2 ; Travel-Related Illness
Czasopismo naukowe
Tytuł:
Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021.
Autorzy:
Bo C; Department of Neurology, XuanWu Hospital, Capital Medical University, Beijing, China.; Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Beijing, China.
Wang T; Department of Neurology, XuanWu Hospital, Capital Medical University, Beijing, China.
Hou C; Center for Evidence-Based Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
Han J; Department of Neurology, XuanWu Hospital, Capital Medical University, Beijing, China.
Chen L; Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Beijing, China.
Zhang H; Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Beijing, China.
Wang L; Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Beijing, China.
Li H; Department of Neurology, Department of General Surgery, China National Clinical Research Center for Geriatric Diseases, XuanWu Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2022 Aug; Vol. 28 (8), pp. 1229-1239. Date of Electronic Publication: 2022 Jun 01.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Ischemic Stroke*/drug therapy
China ; Drug Evaluation ; Fibrinolytic Agents/therapeutic use ; Humans
Czasopismo naukowe
Tytuł:
Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
Autorzy:
Cui W; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, 305 Grattan St, Melbourne, 3000, VIC, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Phillips KA; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, 305 Grattan St, Melbourne, 3000, VIC, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia; Breast Cancer Trials Australia New Zealand (BCT-ANZ), Level 4, 175 Scott St, Newcastle, 2300, NSW, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Francis PA; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, 305 Grattan St, Melbourne, 3000, VIC, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia; Breast Cancer Trials Australia New Zealand (BCT-ANZ), Level 4, 175 Scott St, Newcastle, 2300, NSW, Australia.
Anderson RA; MRC Centre for Reproductive Health, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.
Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.
Loi S; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, 305 Grattan St, Melbourne, 3000, VIC, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia; Division of Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Loibl S; German Breast Group, Martin Behaim Strasse 12, 63263, Neu-Isenburg, Germany; Centre for Haematology and Oncology, Bethanien, Im Prüfling 17, 60389, Frankfurt, Germany.
Keogh L; Centre for Health Equity, The University of Melbourne, Parkville, VIC, 3010, Australia. Electronic address: .
Pokaż więcej
Źródło:
Breast (Edinburgh, Scotland) [Breast] 2022 Aug; Vol. 64, pp. 56-62. Date of Electronic Publication: 2022 May 16.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/toxicity
Breast Neoplasms*/drug therapy
Clinical Trials as Topic*
Ovary*/drug effects
Female ; Humans ; Premenopause ; Qualitative Research ; Research Design/standards
Czasopismo naukowe
Tytuł:
Impact of the Clinical Trials Act 2018 on clinical trial activity in Japan from 2018 to 2020: a retrospective database study using new and conventional Japanese registries.
Autorzy:
Taruno H; Department of Medical Affairs Planning, Daiichi Sankyo, Chuo-ku, Tokyo, Japan .; Department of Clinical Trials Review and Management, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
Oba MS; Department of Medical Statistics, Faculty of Medicine, Toho University, Ota-ku, Tokyo, Japan.
Takizawa O; Daiichi Sankyo, Chuo-ku, Tokyo, Japan.
Kikuchi K; National Center for Child Health and Development, Center for Clinical Research and Development, Setagaya-ku, Tokyo, Japan.
Matsui K; Department of Clinical Development, Daiichi Sankyo RD Novare, Edogawa-ku, Tokyo, Japan.
Shikano M; Faculty of Pharmaceutical Sciences, Tokyo University of Science, Shinjuku-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2022 Jul 18; Vol. 12 (7), pp. e059092. Date of Electronic Publication: 2022 Jul 18.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*/legislation & jurisprudence
Data Management*
Databases, Factual ; Humans ; Japan ; Registries ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Ethics of Early Clinical Trials of Bio-Artificial Organs.
Autorzy:
Bunnik EM; Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
de Jongh D; Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
Massey E; Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
Pokaż więcej
Źródło:
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 Jul 06; Vol. 35, pp. 10621. Date of Electronic Publication: 2022 Jul 06 (Print Publication: 2022).
Typ publikacji:
Congress
MeSH Terms:
Artificial Organs*
Clinical Trials as Topic*/ethics
Humans ; Organ Transplantation ; Regenerative Medicine
Tytuł:
Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials.
Autorzy:
Adams DV; American Cancer Society Cancer Action Network, Washington, DC.
Long S; American Cancer Society Cancer Action Network, Washington, DC.
Fleury ME; American Cancer Society Cancer Action Network, Washington, DC.
Pokaż więcej
Źródło:
JAMA network open [JAMA Netw Open] 2022 Jul 01; Vol. 5 (7), pp. e2220053. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*/instrumentation
Clinical Trials as Topic*/statistics & numerical data
Health Services Accessibility*/statistics & numerical data
Neoplasms*/epidemiology
Neoplasms*/therapy
Patient Participation*
Telemedicine*/instrumentation
Telemedicine*/methods
Telemedicine*/statistics & numerical data
Aged ; Biomedical Research ; Cross-Sectional Studies ; Decision Making ; Female ; Humans ; Male ; Middle Aged ; Surveys and Questionnaires/statistics & numerical data ; Technology
Czasopismo naukowe
Tytuł:
Ensuring diversity in clinical trials: The role of clinical pharmacology.
Autorzy:
Masters JC; Pfizer Inc, 10777 Science Center Dr, San Diego, CA 92121, USA. Electronic address: .
Cook JA; Pfizer Inc, 445 Eastern Point Rd, Groton, CT 06340, USA.
Anderson G; Pfizer Inc, 445 Eastern Point Rd, Groton, CT 06340, USA.
Nucci G; Pfizer Inc, 1 Portland Street, Cambridge, MA 02139, USA.
Colzi A; Pizer Clinical Research Unit, Route de Lennik, 808, Anderlecht, Belgium.
Hellio MP; Pfizer Inc, 235 East 42nd Street, New York, NY 10017, USA.
Corrigan B; Pfizer Inc, 445 Eastern Point Rd, Groton, CT 06340, USA.
Pokaż więcej
Źródło:
Contemporary clinical trials [Contemp Clin Trials] 2022 Jul; Vol. 118, pp. 106807. Date of Electronic Publication: 2022 May 27.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Cultural Diversity*
Pharmacology, Clinical*
Aged ; Child ; Ethnicity ; Humans ; Racial Groups
Czasopismo naukowe
Tytuł:
Re-engineering a Clinical Trial Management System Using Blockchain Technology: System Design, Development, and Case Studies.
Autorzy:
Zhuang Y; National Institute of Health Data Science, Peking University, Beijing, China.; Advanced Institute of Information Technology, Peking University, Hangzhou, China.
Zhang L; National Institute of Health Data Science, Peking University, Beijing, China.; Advanced Institute of Information Technology, Peking University, Hangzhou, China.
Gao X; Department of Statistics, University of Missouri, Columbia, MO, United States.
Shae ZY; Department of Computer Science and Information Engineering, Asia University, Taichung, Taiwan.
Tsai JJP; Department of Computer Science and Information Engineering, Asia University, Taichung, Taiwan.
Li P; Advanced Institute of Information Technology, Peking University, Hangzhou, China.
Shyu CR; Institute for Data Science and Informatics, University of Missouri, Columbia, MO, United States.
Pokaż więcej
Źródło:
Journal of medical Internet research [J Med Internet Res] 2022 Jun 27; Vol. 24 (6), pp. e36774. Date of Electronic Publication: 2022 Jun 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Blockchain*
Clinical Trials as Topic*
Delivery of Health Care ; Engineering ; Humans ; Research Design ; Technology
Czasopismo naukowe
Tytuł:
Quantifying geographical accessibility to cancer clinical trials in different income landscapes.
Autorzy:
Tini G; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milano, Italy.
Trapani D; Division of Early Drug Development, IEO European Institute of Oncology, IRCCS, Milano, Italy.
Duso BA; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milano, Italy.
Beria P; Department of Architecture and Urban Studies (DAStU), Politecnico of Milano, Milano, Italy.
Curigliano G; Division of Early Drug Development, IEO European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.
Pelicci PG; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.
Mazzarella L; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milano, Italy; Division of Early Drug Development, IEO European Institute of Oncology, IRCCS, Milano, Italy. Electronic address: .
Pokaż więcej
Źródło:
ESMO open [ESMO Open] 2022 Jun; Vol. 7 (3), pp. 100515. Date of Electronic Publication: 2022 Jun 21.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Health Services Accessibility*
Neoplasms*/epidemiology
Neoplasms*/therapy
Geography ; Humans ; Incidence ; Income ; Italy/epidemiology ; Registries
Czasopismo naukowe
Tytuł:
Developing lay summaries and thank you notes in paediatric pragmatic clinical trials.
Autorzy:
Zimmerman KO; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Pediatrics, Duke University, Durham, North Carolina, USA.
Perry B; Department of Population Health Sciences, Duke University, Durham, North Carolina, USA.
Hanlen-Rosado E; Department of Population Health Sciences, Duke University, Durham, North Carolina, USA.
Nsonwu A; Department of Population Health Sciences, Duke University, Durham, North Carolina, USA.
Lane MD; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Benjamin DK; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Pediatrics, Duke University, Durham, North Carolina, USA.
Becker M; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Pediatrics, Duke University, Durham, North Carolina, USA.
Corneli A; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Population Health Sciences, Duke University, Durham, North Carolina, USA.
Pokaż więcej
Corporate Authors:
Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee
Źródło:
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2022 Jun; Vol. 25 (3), pp. 1029-1037. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Caregivers*
Communication*
Pragmatic Clinical Trials as Topic*
Adolescent ; Humans
Czasopismo naukowe
Tytuł:
Democratizing data at Novartis through clinical trial data access.
Autorzy:
Eichler GS; Novartis AG, Basel, Switzerland. Electronic address: .
Imbert G; Novartis AG, Basel, Switzerland.
Branson J; Novartis AG, Basel, Switzerland.
Balibey R; Novartis AG, Basel, Switzerland.
Laramie JM; Novartis AG, Basel, Switzerland.
Pokaż więcej
Źródło:
Drug discovery today [Drug Discov Today] 2022 Jun; Vol. 27 (6), pp. 1533-1537. Date of Electronic Publication: 2022 Feb 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Clinical Trials as Topic*
Drug Industry*
Information Dissemination*
Humans
Czasopismo naukowe
Tytuł:
Review of the Chinese Landscape in Phase 1 Clinical Trials for Noncancer Innovative Drugs Over 2015 to 2020.
Autorzy:
Wu X; Clinical Pharmacology Research Center, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Beijing, 100730, China.
Zhang F; Clinical Pharmacology Research Center, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Beijing, 100730, China.
Yu M; Clinical Pharmacology Research Center, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Beijing, 100730, China.
Wang H; Clinical Pharmacology Research Center, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Beijing, 100730, China.
Pokaż więcej
Źródło:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Aug; Vol. 11 (8), pp. 903-909. Date of Electronic Publication: 2022 Jun 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Trials, Phase I as Topic*
Child ; China ; Humans
Czasopismo naukowe
Tytuł:
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.
Autorzy:
Salmanton-García J; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Stewart FA; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Heringer S; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Koniordou M; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
Álvarez-Barco E; Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland.
Argyropoulos CD; European University of Cyprus, Nicosia, Cyprus.
Themistocleous SC; European University of Cyprus, Nicosia, Cyprus.
Valle-Simón P; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain.
Spivak O; Ministry of Health of Israel, Jerusalem, Israel.
Součková L; Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, Czech Republic, CZECRIN, Brno, Czech Republic.
Merakou C; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
Amélia Mendonça M; Centro Hospitalar Universitário do Porto, Porto, Portugal.
Joanna Davis R; University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy.
Maria Azzini A; University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy.
Askling HH; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Vene S; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Van Damme P; Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, Belgium.
Steinbach A; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Shiamakkides G; European University of Cyprus, Nicosia, Cyprus.
Seidel D; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Olesen OF; European Vaccine Initiative (EVI), Heidelberg, Germany.
Noula E; European University of Cyprus, Nicosia, Cyprus.
Macken A; Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland.
Luís C; European Vaccine Initiative (EVI), Heidelberg, Germany.
Leckler J; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Launay O; Institut National de la Santé et de la Recherche Médicale-ANRS Maladies Infectieuses Émergentes, Paris, France; Université Paris Cité, Assistance Publique Hopitaux de Paris, Paris, France.
Isitt C; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Hellemans M; Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, Belgium.
Frías-Iniesta J; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain.
Di Marzo R; European Vaccine Initiative (EVI), Heidelberg, Germany.
Carcas AJ; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain.
Boustras G; European University of Cyprus, Nicosia, Cyprus.
Borobia AM; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain.
Barta I; National Koranyi Institute for Pulmonology, Budapest, Hungary.
Albus K; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Akova M; Haceteppe University, Ankara, Turkey.
Ochando J; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Cohen-Kandli M; Ministry of Health of Israel, Jerusalem, Israel.
Jane Cox R; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Husa P; Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, Czech Republic, CZECRIN, Brno, Czech Republic.
Jancoriene L; Institute of Clinical Medicine, Medical Faculty, Vilnius University|Institute of Clinical Medicine, Medical Faculty, Vilnius University; Vilnius University Hospital Santaros klinikos, Vilnius University, Medical Faculty, Vilnius, Lithuania.
Mallon P; Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland.
Marques L; Centro Hospitalar Universitário do Porto, Porto, Portugal.
Mellinghoff SC; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Nauclér P; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Tacconelli E; University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy.
Tóth K; National Koranyi Institute for Pulmonology, Budapest, Hungary.
Zaoutis TE; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
Zeitlinger M; Medical University of Vienna, Vienna, Austria.
Cornely OA; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany.
Pana ZD; European University of Cyprus, Nicosia, Cyprus.
Pokaż więcej
Corporate Authors:
VACCELERATE consortium
Źródło:
Vaccine [Vaccine] 2022 Jul 29; Vol. 40 (31), pp. 4090-4097. Date of Electronic Publication: 2022 Jun 02.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Clinical Trials as Topic*
Patient Participation*
Adult ; Child ; Europe/epidemiology ; Humans ; Registries ; Volunteers
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz